SusanLMcelroyMD

Clinical Trials

• A Study of Risperidone Monotherapy in Bipolar Anxiety Start of enrollment: 2003 Sep 01

  Completed

  Phase 4

• Zonegran in the Treatment of Binge Eating Disorder Associated With Obesity Start of enrollment: 2005 Aug 01

  Completed

  Phase 3

• Lamotrigine in the Treatment of Binge Eating Disorder Associated With Obesity Start of enrollment: 2006 Mar 01

  Completed

  Phase 3

• Study of Risperidone Monotherapy in Ambulatory Bipolar Disorder With Concurrent Moderately Severe Anxiety and Lifetime Panic or Generalized Anxiety Disorder Start of enrollment: 2004 Feb 01

  Completed

  Phase 3

• Study of Quetiapine Monotherapy in Ambulatory Bipolar Spectrum Disorder With Moderate-to-Severe Hypomanic Symptoms or Mild Manic Symptoms Start of enrollment: 2004 Feb 01

  Completed

  Phase 3

• Study of Divalproex Extended Release Monotherapy in Ambulatory Bipolar Spectrum Disorder With Moderate-to-Severe Hypomania or Mild Mania Start of enrollment: 2003 Aug 01

  Completed

  Phase 3

• Atomoxetine in the Treatment of Binge Eating Disorder Start of enrollment: 2006 May 01

  Completed

  Phase 4

• A Preliminary Study of the Effectiveness and Tolerability of Aripiprazole in Bipolar Depression Start of enrollment: 2006 Aug 01

  Completed

  Phase 4

• Safety and Efficacy Trial of Olanzapine in Outpatients With Pathological Gambling Start of enrollment: 2007 Feb 01

  Completed

  Phase 3

• Acamprosate in the Treatment of Binge-Eating Disorder Start of enrollment: 2007 Apr 01

  Completed

  Phase 2, Phase 3

• Sodium Oxybate in the Treatment of Binge Eating Disorder Start of enrollment: 2007 Aug 01

  Completed

  Phase 2, Phase 3

• Add-On Ramelteon in Bipolar I Disorder With Clinically Significant Sleep Disturbance Start of enrollment: 2007 Dec 01

  Terminated

  Phase 3

• Efficacy and Safety Study of Low-Dose Ondansetron For Adjunctive Therapy In Adult Patients With Obsessive-Compulsive Disorder Start of enrollment: 2011 Jan 01

  Terminated

  Phase 2

• SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder Start of enrollment: 2012 Nov 26

  Completed

  Phase 3

• SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder Start of enrollment: 2012 Nov 26

  Completed

  Phase 3

• Study of Intravenous NRX-1074 in Patients With Major Depressive Disorder Start of enrollment: 2014 Mar 01

  Completed

  Phase 2

• Join now to see all